Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 4
3(75.0%)
N/A
1(25.0%)
4Total
Phase 4(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07274046Recruiting

Burden of Tick-borne Encephalitis and Cost-effectiveness of Vaccination in the Czech Republic

Role: collaborator

NCT06907316Phase 4Terminated

Cefixime Versus Benzathine Penicillin G in Treatment of Early Syphilis

Role: lead

NCT06499623Recruiting

Early Detection of Malnutrition in Oncology Patients and Elderly Patients

Role: collaborator

NCT04671914Phase 4Recruiting

Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.

Role: collaborator

NCT06090565Phase 4Completed

Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea

Role: lead

NCT05644990Unknown

T2MR PCR Detection of ESKAPE Pathogens in Patients With Pyogenic Spondylodiscitis and Infective Endocarditis

Role: collaborator

NCT01979757Not ApplicableCompleted

Outcomes After Centrifugation Versus PureGraft for Fatgrafting to the Breast

Role: lead

NCT01586559Completed

Evaluation of the Long-term Stability of Sheath Plication Using Absorbable Sutures in Patients With Diastasis of the Recti Muscles: an Ultrasonography Study

Role: lead

All 8 trials loaded